In commenting on the new IMS Pharma Letter, we highlight the emergence and widespread build up of the consumer’s role in prevention, care and outcomes. Consumer centricity is being driven by the rise of CDHP (consumer directed health plans), but it’s quite different from these insurance products, with their high deductibles and variable co-pays.
Consumers are learning and experiencing more about consumer-directed health plans (CDHP) as they enter the exchanges, even though CDHP has been around for fifteen years or more. Most new health insurance products have a deductible that must be met, so consumers must pay for services and treatments until they reach that goal. NOTE: the ACA (Obamacare) mandates that no individual pay more than $6350 in total out-of-pocket costs in Y2014). If they have not paid the sum, they will pay more of their own money for the care.
Consumer centricity in health care means that control for choice of service and for outcomes will shift to the consumers and they will become the ultimate arbiters in their health and health care. It’s a value-based concept that drives this shift in decision-making. IT supports the data so that the consumer can decide where, when, why and who to choose for care based upon personal preferences and goals, total costs, incentives to engage and time to get to the outcome preferred. (more…)